ArticlemedRxiv : the preprint server for health sciences2022
People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses.
Hope R Lapointe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.